Evidence map›Paper›PMID 35543800›Full record

ArticleJournal of molecular neuroscience : MN2022

Sinomenine Attenuates Trimethyltin-Induced Cognitive Decline via Targeting Hippocampal Oxidative Stress and Neuroinflammation.

Amir Rostami, Fatemeh Taleahmad, Narges Haddadzadeh-Niri, Ensiye Joneidi, Siamak Afshin-Majd, Tourandokht Baluchnejadmojarad, Mehrdad Roghani

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular neuroscience : MN, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
7.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Sinomenine protects mice againstMicrobiology spectrum · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. The role of NLRP3 inflammasome-mediated pyroptosis in astrocytes during hyperoxia-induced brain injury.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. The Mechanism of TNF-Oxidative medicine and cellular longevity · 2022
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Amir RostamiSchool of Medicine, Shahed University, Tehran, Iran.
Fatemeh TaleahmadDepartment of Physiology, School of Medicine, Shahed University, Tehran, Iran.
Narges Haddadzadeh-NiriDepartment of Physiology, School of Medicine, Shahed University, Tehran, Iran.
Ensiye JoneidiDepartment of Biology, Faculty of Basic Sciences, Shahed University, Tehran, Iran.
Siamak Afshin-MajdNeurophysiology Research Center, Shahed University, Tehran, Iran.
Tourandokht BaluchnejadmojaradDepartment of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mehrdad RoghaniNeurophysiology Research Center, Shahed University, Tehran, Iran. mehjour@yahoo.com.ORCID http://orcid.org/0000-0002-9209-8484
Shahed University · IRIran University of Medical Sciences · IR

Funding

National Institute for Medical Research Development 996144
6 · The paper itself

Abstract

Sinomenine is the main bioactive ingredient of the medicinal plant Sinomenium acutum with neuroprotective potential. This study was designed to assess beneficial effect of sinomenine in alleviation of trimethyltin (TMT)-induced cognitive dysfunction. TMT was administered i.p. (8 mg/kg, once) and sinomenine was daily given p.o. 1 h after TMT for 3 weeks at doses of 25 or 100 mg/kg. Cognitive performance was assessed in various behavioral tests. In addition, oxidative stress- and inflammation-associated factors were measured and histochemical evaluation of the hippocampus was conducted. Sinomenine at a dose of 100 mg/kg significantly and partially increased discrimination index in novel object recognition (NOR), improved alternation in short-term Y maze, increased step-through latency in passive avoidance paradigm, and also reduced probe trial errors and latency in the Barnes maze task. Moreover, sinomenine somewhat prevented inappropriate hippocampal changes of malondialdehyde (MDA), reactive oxygen species (ROS), protein carbonyl, nitrite, superoxide dismutase (SOD), tumor necrosis factor α (TNFα), interleukin 6 (IL 6), acetylcholinesterase (AChE) activity, beta secretase 1 (BACE 1) activity, and mitochondrial membrane potential (MMP) with no significant effect on glutathione (GSH), catalase, glutathione reductase, glutathione peroxidase, and myeloperoxidase (MPO). In addition, lower reactivity (IRA) for glial fibrillary acidic protein (GFAP) as an index of astrocyte activity was observed and loss of CA1 pyramidal neurons was attenuated following sinomenine treatment. This study demonstrated that sinomenine could lessen TMT-induced cognitive dysfunction which is partly due to its attenuation of hippocampal oxidative stress and neuroinflammation.

Indexed as

Cognitive DysfunctionNeuroprotective AgentsAcetylcholinesteraseAnimalsGlutathioneHippocampusMaze LearningMorphinansNeuroinflammatory DiseasesOxidative StressRatsRats, WistarTrimethyltin CompoundsAcetylcholinesteraseGlutathioneMorphinansNeuroprotective AgentssinomeninetrimethyltinTrimethyltin CompoundsAlzheimer’s diseaseNeuroinflammationNeuroprotectionOxidative stressSinomenineTrimethyltin

Identifiers

PMID35543800
OpenAlexW4280537093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.